KalVista Pharmaceuticals, Inc. (KALV)

17.06 +0.16 (+0.95%) USD  |  NASDAQ  |  Dec 12, 14:33
More

KalVista Pharmaceuticals Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Silvergate Capital Corp. --
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Free Cash Flow Yield Upgrade